 | Up a level |
Ayçiçek, Selin G; Akhoundova, Dilara; Bacher, Ulrike; Hayoz, Michael; Aebi, Yolanda; Largiadèr, Carlo R.; Pabst, Thomas (2024). Determinants of Interpatient Variability in Treosulfan Pharmacokinetics in AML Patients Undergoing Autologous Stem Cell Transplantation. International journal of molecular sciences, 25(15) MDPI 10.3390/ijms25158215
Martinez Flores, Danaë; Akhoundova, Dilara; Seipel, Katja; Legros, Myriam; Kronig, Marie-Noelle; Daskalakis, Michael; Bacher, Ulrike; Pabst, Thomas (2024). Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia. Biomedicines, 12(7) MDPI 10.3390/biomedicines12071616
Akhoundova, Dilara; Fischer, Stefanie; Triscott, Joanna; Lehner, Marika; Thienger, Phillip; Maletti, Sina; Jacquet, Muriel; Lubis, Dinda S H; Bubendorf, Lukas; Jochum, Wolfram; Rubin, Mark A (2024). Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical course. Diagnostic pathology, 19(1) BioMed Central 10.1186/s13000-024-01511-3
Eggimann, Matthias; Akhoundova, Dilara; Nilius, Henning; Hoffmann, Michèle; Hayoz, Michael; Aebi, Yolanda; Largiadèr, Carlo R; Daskalakis, Michael; Bacher, Ulrike; Pabst, Thomas (2024). Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation. Cancers, 16(10) MDPI AG 10.3390/cancers16101887
Mehl, Julian; Akhoundova, Dilara; Bacher, Ulrike; Jeker, Barbara; Rhyner Agocs, Gaëlle; Ruefer, Axel; Soltermann, Susanne; Soekler, Martin; Winkler, Annette; Daskalakis, Michael; Pabst, Thomas (2024). Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery. Cancers, 16(10) MDPI AG 10.3390/cancers16101854
Akhoundova, Dilara; Francica, Paola; Rottenberg, Sven; Rubin, Mark A (2024). DNA Damage Response and Mismatch Repair Gene Defects in Advanced and Metastatic Prostate Cancer. Advances in anatomic pathology, 31(2), pp. 61-69. Lippincott Williams & Wilkins 10.1097/PAP.0000000000000422
Akhoundova, Dilara; Rubin, Mark Andrew (2024). The grand challenge of moving cancer whole-genome sequencing into the clinic. Nature medicine, 30(1), pp. 39-40. Nature Publishing Group 10.1038/s41591-023-02697-7
Shumilov, Evgenii; Boyadzhiev, Hristo; Mazzeo, Paolo; Akhoundova, Dilara; Daskalakis, Michael; Novak, Urban; Lenz, Georg; Bacher, Ulrike; Pabst, Thomas (2023). CAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS Involvement. HemaSphere, 7(12), e984. Wolters Kluwer Health 10.1097/HS9.0000000000000984
Speicher, Philip; Fankhauser, Christian D; Lorch, Anja; Ardizzone, Davide; Helnwein, Simon; Hoch, Dennis; Hermanns, Thomas; Beyer, Jörg; Akhoundova, Dilara (2023). Excellent survival in relapsed stage I testicular cancer. BMC cancer, 23(1), p. 870. BioMed Central 10.1186/s12885-023-11388-y
Gillich, Cédric; Akhoundova, Dilara; Hayoz, Michael; Aebi, Yolanda; Largiadèr, Carlo R; Seipel, Katja; Daskalakis, Michael; Bacher, Vera; Pabst, Thomas (2023). Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma. Cancers, 15(10) MDPI AG 10.3390/cancers15102699
Akhoundova, Dilara; Beyer, Jörg (2023). Weitere Fortschritte bei Blasen- und Hodenkrebs (In Press). Leading Opinions. Hämatologie & Onkologie Universimed
Gallon, John; Rodríguez-Calero, Antonio; Benjak, Andrej; Akhoundova, Dilara; Maletti, Sina; Amstutz, Ursula; Hewer, Ekkehard; Genitsch, Vera; Fleischmann, Achim; Rushing, Elisabeth J; Grobholz, Rainer; Fischer, Ingeborg; Jochum, Wolfram; Cathomas, Gieri; Osunkoya, Adeboye O; Bubendorf, Lukas; Moch, Holger; Thalmann, George; Feng, Felix Y; Gillessen, Silke; ... (2023). DNA methylation landscapes of prostate cancer brain metastasis are shaped by early driver genetic alterations. Cancer research, 83(8), pp. 1203-1213. American Association for Cancer Research AACR 10.1158/0008-5472.CAN-22-2236
Wittibschlager, Valerie; Bacher, Ulrike; Seipel, Katja; Porret, Naomi; Wiedemann, Gertrud; Haslebacher, Claudia; Hoffmann, Michèle; Daskalakis, Michael; Akhoundova, Dilara; Pabst, Thomas (2023). CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma. International journal of molecular sciences, 24(6) MDPI 10.3390/ijms24065688
Lakomy, Tim; Akhoundova, Dilara; Nilius, Henning; Kronig, Marie-Noëlle; Novak, Urban; Daskalakis, Michael; Bacher, Ulrike; Pabst, Thomas (2023). Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules, 13(2) MDPI 10.3390/biom13020382
Bühler, Selina; Akhoundova, Dilara; Jeker, Barbara; Legros, Myriam; Seipel, Katja; Daskalakis, Michael; Bacher, Ulrike; Pabst, Thomas (2023). Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma. Cancers, 15(2) MDPI AG 10.3390/cancers15020430
Hoch, Dennis; Rabaglio, Manuela; Grob, Tobias; von Gunten, Michael; Beyer, Jörg; Akhoundova, Dilara (2023). Exceptional Response to Pembrolizumab in a Mismatch Repair-Deficient Aggressive Prostate Cancer with Somatic EPCAM, MSH2, and MSH6 Co-Deletion: A Case Report. Case reports in oncology, 16(1), pp. 1280-1286. Karger 10.1159/000534177
Seipel, Katja; Frey, Michèle; Nilius, Henning; Akhoundova, Dilara; Banz, Yara; Bacher, Ulrike; Pabst, Thomas (2023). Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. Current oncology, 30(12), pp. 10463-10476. MDPI 10.3390/curroncol30120762
Akhoundova, Dilara; Hussung, Saskia; Sivakumar, Smruthy; Töpfer, Antonia; Rechsteiner, Markus; Kahraman, Abdullah; Arnold, Fabian; Angst, Florian; Britschgi, Christian; Zoche, Martin; Moch, Holger; Weber, Achim; Sokol, Ethan; Fritsch, Ralph M (2022). ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer. International journal of cancer, 151(12), pp. 2161-2171. Wiley-Blackwell 10.1002/ijc.34257
Akhoundova, Dilara; Feng, Felix Y; Pritchard, Colin C; Rubin, Mark A (2022). Molecular Genetics of Prostate Cancer and Role of Genomic Testing. Surgical pathology clinics, 15(4), pp. 617-628. 10.1016/j.path.2022.08.002
Akhoundova, Dilara; Rubin, Mark A (2022). Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future. Cancer cell, 40(9), pp. 920-938. Cell Press 10.1016/j.ccell.2022.08.011
Akhoundova, Dilara; Haberecker, Martina; Fritsch, Ralph; Höller, Sylvia; Kiessling, Michael K; Rechsteiner, Markus; Rüschoff, Jan H; Curioni-Fontecedro, Alessandra (2022). Targeting ALK in Neuroendocrine Tumors of the Lung. Frontiers in oncology, 12, p. 911294. Frontiers Research Foundation 10.3389/fonc.2022.911294
Rodriguez-Calero, Antonio; Gallon, John; Akhoundova, Dilara; Maletti, Sina; Ferguson, Alison; Cyrta, Joanna; Amstutz, Ursula; Garofoli, Andrea; Paradiso, Viola; Tomlins, Scott A; Hewer, Ekkehard; Genitsch, Vera; Fleischmann, Achim; Vassella, Erik; Rushing, Elisabeth J; Grobholz, Rainer; Fischer, Ingeborg; Jochum, Wolfram; Cathomas, Gieri; Osunkoya, Adeboye O; ... (2022). Alterations in homologous recombination repair genes in prostate cancer brain metastases. Nature Communications, 13(1), p. 2400. Springer Nature 10.1038/s41467-022-30003-5
Hiltbrunner, Stefanie; Spohn, Meta-Lina; Wechsler, Ramona; Akhoundova, Dilara; Bankel, Lorenz; Kasser, Sabrina; Bihr, Svenja; Britschgi, Christian; Maathuis, Marloes H; Curioni-Fontecedro, Alessandra (2022). Comprehensive Statistical Exploration of Prognostic (Bio-)Markers for Responses to Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer. Cancers, 14(1) MDPI AG 10.3390/cancers14010075
Akhoundova, Dilara; Pietge, Heike; Hussung, Saskia; Kiessling, Michael; Britschgi, Christian; Zoche, Martin; Rechsteiner, Markus; Weber, Achim; Fritsch, Ralph M (2021). Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal Cancer. JCO precision oncology, 5, pp. 1082-1087. American Society of Clinical Oncology 10.1200/PO.21.00107
